These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 35352102

  • 1. Low Prior Exposure and Incidence of Hepatitis C in Human Immunodeficiency Virus-Negative Gay and Bisexual Men Taking Preexposure Prophylaxis (PrEP): Findings From the Expanded PrEP Implementation in Communities-New South Wales Prospective Implementation Study.
    Amin J, Vaccher S, Templeton DJ, Bavinton B, Jin F, Zablotska I, Matthews G, Ogilvie E, Yeung B, Ooi C, Dharan N, Baker DA, Read P, Guy R, Grulich AE.
    Clin Infect Dis; 2022 Oct 29; 75(9):1497-1502. PubMed ID: 35352102
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Expanded HIV pre-exposure prophylaxis (PrEP) implementation in communities in New South Wales, Australia (EPIC-NSW): design of an open label, single arm implementation trial.
    Zablotska IB, Selvey C, Guy R, Price K, Holden J, Schmidt HM, McNulty A, Smith D, Jin F, Amin J, Cooper DA, Grulich AE, EPIC-NSW study group.
    BMC Public Health; 2018 Feb 02; 18(1):210. PubMed ID: 29394918
    [Abstract] [Full Text] [Related]

  • 5. Comparison of Trends in Rates of Sexually Transmitted Infections Before vs After Initiation of HIV Preexposure Prophylaxis Among Men Who Have Sex With Men.
    McManus H, Grulich AE, Amin J, Selvey C, Vickers T, Bavinton B, Zablotska I, Vaccher S, Jin F, Holden J, Price K, Yeung B, Cabrera Quichua G, Ogilvie E, McNulty A, Smith D, Guy R.
    JAMA Netw Open; 2020 Dec 01; 3(12):e2030806. PubMed ID: 33355675
    [Abstract] [Full Text] [Related]

  • 6. Association of HIV Preexposure Prophylaxis With Incidence of Sexually Transmitted Infections Among Individuals at High Risk of HIV Infection.
    Traeger MW, Cornelisse VJ, Asselin J, Price B, Roth NJ, Willcox J, Tee BK, Fairley CK, Chang CC, Armishaw J, Vujovic O, Penn M, Cundill P, Forgan-Smith G, Gall J, Pickett C, Lal L, Mak A, Spelman TD, Nguyen L, Murphy DA, Ryan KE, El-Hayek C, West M, Ruth S, Batrouney C, Lockwood JT, Hoy JF, Hellard ME, Stoové MA, Wright EJ, PrEPX Study Team.
    JAMA; 2019 Apr 09; 321(14):1380-1390. PubMed ID: 30964528
    [Abstract] [Full Text] [Related]

  • 7. Brief Report: Low Incidence of Hepatitis C Among a Cohort of HIV-Negative Gay and Bisexual Men Using HIV Pre-exposure Prophylaxis (PrEP) in Melbourne, Australia, and the Contribution of Sexual Transmission.
    Cornelisse VJ, Traeger MW, Wright EJ, Murphy D, Stoové M, Hellard M, Sacks-Davis R, Asselin J, Fairley CK, Doyle J, Sasadeusz J.
    J Acquir Immune Defic Syndr; 2021 Aug 01; 87(4):1011-1015. PubMed ID: 33770064
    [Abstract] [Full Text] [Related]

  • 8. The Incidence of Hepatitis C Among Gay, Bisexual, and Other Men Who Have Sex With Men in Australia, 2009-2019.
    Harney BL, Sacks-Davis R, van Santen DK, Traeger M, Wilkinson AL, Asselin J, El-Hayek C, Fairley CK, Roth N, Bloch M, Matthews G, Donovan B, Guy R, Stoové M, Hellard ME, Doyle JS, Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of Sexually Transmissible Infections and Blood-borne Viruses (ACCESS).
    Clin Infect Dis; 2022 May 30; 74(10):1804-1811. PubMed ID: 34698338
    [Abstract] [Full Text] [Related]

  • 9. Characteristics of Human Immunodeficiency Virus (HIV) Seroconversions in a Large Prospective Implementation Cohort Study of Oral HIV Preexposure Prophylaxis in Men Who Have Sex with Men (EPIC-NSW).
    Dharan NJ, Jin F, Vaccher S, Bavinton B, Yeung B, Guy R, Carr A, Zablotska I, Amin J, Read P, Templeton DJ, Ooi C, Martin SJ, Ryder N, Smith DE, McNulty A, Brown K, Price K, Holden J, Grulich AE, Expanded PrEP Implementation in Communities in New South Wales (EPIC-NSW) research group.
    Clin Infect Dis; 2023 Feb 08; 76(3):e622-e628. PubMed ID: 35982613
    [Abstract] [Full Text] [Related]

  • 10. Real-world trends in incidence of bacterial sexually transmissible infections among gay and bisexual men using HIV pre-exposure prophylaxis (PrEP) in Australia following nationwide PrEP implementation: an analysis of sentinel surveillance data.
    Traeger MW, Guy R, Asselin J, Patel P, Carter A, Wright EJ, Grulich A, McManus H, Fairley CK, Chow EPF, McNulty A, Finlayson R, Bell C, Owen L, Marshall L, Russell D, O'Donnell D, Donovan B, Hellard ME, Stoové MA, Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of Sexually Transmissible Infections and Blood Borne Viruses (ACCESS) Study Group.
    Lancet Infect Dis; 2022 Aug 08; 22(8):1231-1241. PubMed ID: 35643090
    [Abstract] [Full Text] [Related]

  • 11. Hepatitis C testing among three distinct groups of gay, bisexual and other men who have sex with men: a cross-sectional study in the Celtic nations.
    Whiteley D, Strongylou D, Brown S, Vickerman P, Frankis JS.
    Sex Transm Infect; 2023 Nov 08; 99(7):440-446. PubMed ID: 37045586
    [Abstract] [Full Text] [Related]

  • 12. Incidence of Hepatitis C Virus Infections Among Users of Human Immunodeficiency Virus Pre-exposure Prophylaxis.
    Tabatabavakili S, Aleyadeh W, Cerrocchi O, Janssen HLA, Hansen BE, Bogoch II, Feld JJ, Viral Hepatitis Care Network Investigators.
    Clin Gastroenterol Hepatol; 2022 Mar 08; 20(3):674-681. PubMed ID: 33737225
    [Abstract] [Full Text] [Related]

  • 13. Association of HIV Preexposure Prophylaxis Use With HIV Incidence Among Men Who Have Sex With Men in China: A Nonrandomized Controlled Trial.
    Wang H, Wang Z, Huang X, Chen Y, Wang H, Cui S, Zhang J, Chu Z, Hu Q, Ding H, Qian H, Zou H, Tang W, Gao Y, Jin X, Liu Z, Zhang L, Zhao J, He X, Jiang Y, Geng W, Xu J, Shang H, China Real-World Oral Intake of PrEP (CROPrEP) Study Team.
    JAMA Netw Open; 2022 Feb 01; 5(2):e2148782. PubMed ID: 35171258
    [Abstract] [Full Text] [Related]

  • 14. Protocol for an open-label, single-arm trial of HIV pre-exposure prophylaxis (PrEP) among people at high risk of HIV infection: the NSW Demonstration Project PRELUDE.
    Vaccher S, Grulich A, McAllister J, Templeton DJ, Bloch M, McNulty A, Holden J, Poynten IM, Prestage G, Zablotska I, PRELUDE Study Team.
    BMJ Open; 2016 Jun 20; 6(6):e012179. PubMed ID: 27324719
    [Abstract] [Full Text] [Related]

  • 15. Hepatitis C virus infection is uncommon at baseline and during follow-up among individuals using PrEP in the Dutch national PrEP programme between 2019 and 2022.
    Hage K, Boyd A, Op de Coul ELM, Sarink D, Hoornenborg E, Prins M.
    Sex Transm Infect; 2024 Jul 26; 100(5):288-294. PubMed ID: 38914472
    [Abstract] [Full Text] [Related]

  • 16. Same-day initiation of oral pre-exposure prophylaxis among gay, bisexual, and other cisgender men who have sex with men and transgender women in Brazil, Mexico, and Peru (ImPrEP): a prospective, single-arm, open-label, multicentre implementation study.
    Veloso VG, Cáceres CF, Hoagland B, Moreira RI, Vega-Ramírez H, Konda KA, Leite IC, Bautista-Arredondo S, Vinícius de Lacerda M, Valdez Madruga J, Farias A, Lima JN, Zonta R, Lauria L, Tamayo CVO, Flores HJS, Santa Cruz YMC, Aguayo RMM, Cunha M, Moreira J, Makkeda AR, Díaz S, Guanira JV, Vermandere H, Benedetti M, Ingold HL, Pimenta MC, Torres TS, Grinsztejn B, ImPrEP Study Group.
    Lancet HIV; 2023 Feb 26; 10(2):e84-e96. PubMed ID: 36565708
    [Abstract] [Full Text] [Related]

  • 17. Adherence to daily HIV pre-exposure prophylaxis in a large-scale implementation study in New South Wales, Australia.
    Jin F, Amin J, Guy R, Vaccher S, Selvey C, Zablotska I, Holden J, Price K, Yeung B, Ogilvie E, Quichua GC, Clackett S, McNulty A, Smith D, Templeton DJ, Bavinton B, Grulich AE, Expanded PrEP Implementation in Communities New South Wales (EPIC-NSW) research group.
    AIDS; 2021 Oct 01; 35(12):1987-1996. PubMed ID: 34101630
    [Abstract] [Full Text] [Related]

  • 18. Prevalence and incidence of hepatitis C infection amongst men who have sex with men in a population-based pre-exposure prophylaxis program in British Columbia, Canada.
    Thompson KA, Blank G, Toy J, Moore DM, Lachowsky N, Bacani N, Zhang W, Sereda P, Lima VD, Barrios R, Montaner JSG, Hull MW.
    Liver Int; 2022 Jul 01; 42(7):1528-1535. PubMed ID: 35274805
    [Abstract] [Full Text] [Related]

  • 19. High incidence of HCV in HIV-negative men who have sex with men using pre-exposure prophylaxis.
    Hoornenborg E, Coyer L, Boyd A, Achterbergh RCA, Schim van der Loeff MF, Bruisten S, de Vries HJC, Koopsen J, van de Laar TJW, Prins M, Amsterdam PrEP Project team in the HIV Transmission Elimination AMsterdam (H-TEAM) Initiative.
    J Hepatol; 2020 May 01; 72(5):855-864. PubMed ID: 31862485
    [Abstract] [Full Text] [Related]

  • 20. On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trial.
    Antoni G, Tremblay C, Delaugerre C, Charreau I, Cua E, Rojas Castro D, Raffi F, Chas J, Huleux T, Spire B, Capitant C, Cotte L, Meyer L, Molina JM, ANRS IPERGAY study group.
    Lancet HIV; 2020 Feb 01; 7(2):e113-e120. PubMed ID: 31784343
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.